US Patent Issued to NUECOLOGY BIOMEDICAL on June 9 for "Synergistic anti-viral pharmaceutical composition containing targeting nanoparticles" (Canadian Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,915, issued on June 9, was assigned to NUECOLOGY BIOMEDICAL INC. (Richmond, Canada).

"Synergistic anti-viral pharmaceutical composition containing targeting nanoparticles" was invented by Chung Chin Sun (Richmond, Canada) and Dean Mo Liu (Surrey, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a dual-drag-containing nanoparticle, in which a first antiviral drag, such as remdesivir and a second antiviral drag are co-encapsulated and co-delivered by the nanoparticle, said nanoparticle comprising an alginate-oleic acid particle. The disclosure also relates to the therapeutic use of the nanoparticle in treating viral...